HUTCHMED(HCM) - 2023 Q4 - Earnings Call Transcript

HUTCHMED (China) Limited (NASDAQ:HCM) Q4 2023 Results Conference Call February 28, 2024 7:30 AM ET Company Participants Mark Lee - Senior Vice President of Corporate Management & Communications Dr. Wei-Guo Su - CEO, Chief Scientific Officer Johnny Cheng - CFO Zhenping Wu - Executive Vice President of Pharmaceutical Science & Manufacturing Michael Shi - Executive VP, Head of R&D and Chief Medical Officer Conference Call Participants Louise Alesandra Chen - Cantor Fitzgerald & Co Alec Warren Stranahan - Bank ...